Clinical Trials Directory

Trials / Completed

CompletedNCT01214005

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Brown University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This project tests two hypotheses concerning the low smoking cessation rates in smokers with schizophrenia. The first hypothesis is that smokers with schizophrenia experience stronger and more sustained effects of smoking abstinence on negative mood and smoking urge than control smokers without psychiatric illness. The second hypothesis is that smokers with schizophrenia experience stronger reinforcing effects of a smoking lapse (i.e., more rewarding effects of smoking after a period of abstinence) than control smokers without psychiatric illness.

Detailed description

In this study, smokers with schizophrenia and smokers without psychiatric illness participate in a nicotine preference task before and after a 3-day period of continuous smoking abstinence. The investigators will experimentally control abstinence by providing participants with high-value cash incentives contingent upon smoking abstinence verified with breath carbon monoxide levels. The investigators will measure nicotine withdrawal and smoking urge during the abstinence period. In the nicotine preference task, participants will make choices between nicotine-containing and denicotinized cigarette puffs to provide a measure of nicotine reinforcement, and the investigators will also measure the effects of smoking on mood. After the second nicotine preference task, participants will receive a small-value reinforcer if they continue to abstain for another day, and the investigators will measure time to the second lapse.

Conditions

Interventions

TypeNameDescription
BEHAVIORALsmoking abstinence3 days of biologically-confirmed smoking abstinence

Timeline

Start date
2009-06-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2010-10-04
Last updated
2012-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01214005. Inclusion in this directory is not an endorsement.

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls (NCT01214005) · Clinical Trials Directory